Bio-View Ltd (TLV:BIOV)
Israel · Delayed Price · Currency is ILS · Price in ILA 129.80
-2.00 (-1.52%)
Jun 10, 2026, 2:23 PM IDT
Bio-View Market Cap
Bio-View has a market cap or net worth of 17.66 million as of June 10, 2026. Its market cap has decreased by -53.51% in one year.
Market Cap
17.66M
Enterprise Value
13.24M
Revenue
19.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
129.80
Market Cap Chart
Since April 3, 2006, Bio-View's market cap has decreased from 59.79M to 17.66M, a decrease of -70.46%. That is a compound annual growth rate of -5.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 17.66M | -21.08% |
| Dec 31, 2025 | 22.38M | -37.30% |
| Dec 31, 2024 | 35.69M | -21.62% |
| Dec 31, 2023 | 45.53M | -10.12% |
| Dec 29, 2022 | 50.66M | 13.09% |
| Dec 30, 2021 | 44.79M | -20.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 113.51B |
| Danel (Adir Yeoshua) | 2.74B |
| Amal Holdings A.D. | 2.52B |
| BrainsWay | 1.72B |
| BioLight Life Sciences | 24.30M |
| Erika Carmel-Tech | 22.21M |
| Can-Fite BioPharma | 19.55M |
| Purple Biotech | 18.65M |